These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31498123)

  • 1. Exosomal HSP70 for Monitoring of Frontotemporal Dementia and Alzheimer's Disease: Clinical and FDG-PET Correlation.
    Chanteloup G; Cordonnier M; Moreno-Ramos T; Pytel V; Matías-Guiu J; Gobbo J; Cabrera-Martín MN; Gómez-Pinedo U; Garrido C; Matías-Guiu JA
    J Alzheimers Dis; 2019; 71(4):1263-1269. PubMed ID: 31498123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease.
    Goetzl EJ; Kapogiannis D; Schwartz JB; Lobach IV; Goetzl L; Abner EL; Jicha GA; Karydas AM; Boxer A; Miller BL
    FASEB J; 2016 Dec; 30(12):4141-4148. PubMed ID: 27601437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease.
    Goetzl EJ; Boxer A; Schwartz JB; Abner EL; Petersen RC; Miller BL; Kapogiannis D
    Neurology; 2015 Jul; 85(1):40-7. PubMed ID: 26062630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study.
    Fiandaca MS; Kapogiannis D; Mapstone M; Boxer A; Eitan E; Schwartz JB; Abner EL; Petersen RC; Federoff HJ; Miller BL; Goetzl EJ
    Alzheimers Dement; 2015 Jun; 11(6):600-7.e1. PubMed ID: 25130657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?
    Verfaillie SC; Adriaanse SM; Binnewijzend MA; Benedictus MR; Ossenkoppele R; Wattjes MP; Pijnenburg YA; van der Flier WM; Lammertsma AA; Kuijer JP; Boellaard R; Scheltens P; van Berckel BN; Barkhof F
    Eur Radiol; 2015 Oct; 25(10):3050-9. PubMed ID: 25899416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
    Foster NL; Heidebrink JL; Clark CM; Jagust WJ; Arnold SE; Barbas NR; DeCarli CS; Turner RS; Koeppe RA; Higdon R; Minoshima S
    Brain; 2007 Oct; 130(Pt 10):2616-35. PubMed ID: 17704526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease.
    Kapogiannis D; Boxer A; Schwartz JB; Abner EL; Biragyn A; Masharani U; Frassetto L; Petersen RC; Miller BL; Goetzl EJ
    FASEB J; 2015 Feb; 29(2):589-96. PubMed ID: 25342129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
    Kobylecki C; Langheinrich T; Hinz R; Vardy ER; Brown G; Martino ME; Haense C; Richardson AM; Gerhard A; Anton-Rodriguez JM; Snowden JS; Neary D; Pontecorvo MJ; Herholz K
    J Nucl Med; 2015 Mar; 56(3):386-91. PubMed ID: 25655625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease.
    Goetzl EJ; Mustapic M; Kapogiannis D; Eitan E; Lobach IV; Goetzl L; Schwartz JB; Miller BL
    FASEB J; 2016 Nov; 30(11):3853-3859. PubMed ID: 27511944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.
    Morinaga A; Ono K; Ikeda T; Ikeda Y; Shima K; Noguchi-Shinohara M; Samuraki M; Yanase D; Yoshita M; Iwasa K; Mastunari I; Yamada M
    Dement Geriatr Cogn Disord; 2010; 30(4):285-92. PubMed ID: 20861634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and prognosis of prodromal Alzheimer's disease as assessed by magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography in a community: reanalysis from the Osaki-Tajiri Project.
    Meguro K; Akanuma K; Meguro M; Yamaguchi S; Ishii H; Tashiro M
    Psychogeriatrics; 2016 Mar; 16(2):116-20. PubMed ID: 26114837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of
    Ortner MM
    Methods Mol Biol; 2018; 1750():213-219. PubMed ID: 29512075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
    Shea YF; Ha J; Lee SC; Chu LW
    Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of molecular imaging on the diagnostic process in a memory clinic.
    Ossenkoppele R; Prins ND; Pijnenburg YA; Lemstra AW; van der Flier WM; Adriaanse SF; Windhorst AD; Handels RL; Wolfs CA; Aalten P; Verhey FR; Verbeek MM; van Buchem MA; Hoekstra OS; Lammertsma AA; Scheltens P; van Berckel BN
    Alzheimers Dement; 2013 Jul; 9(4):414-21. PubMed ID: 23164552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series.
    Moodley KK; Perani D; Minati L; Della Rosa PA; Pennycook F; Dickson JC; Barnes A; Contarino VE; Michopoulou S; D'Incerti L; Good C; Fallanca F; Vanoli EG; Ell PJ; Chan D
    J Alzheimers Dis; 2015; 46(3):639-53. PubMed ID: 26402512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography diagnosis of Alzheimer's disease.
    Coleman RE
    Neuroimaging Clin N Am; 2005 Nov; 15(4):837-46, x. PubMed ID: 16443494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain fluorodeoxyglucose (FDG) PET in dementia.
    Kato T; Inui Y; Nakamura A; Ito K
    Ageing Res Rev; 2016 Sep; 30():73-84. PubMed ID: 26876244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological (Dis)Similarities in Neuronal Exosome-Derived Synaptic and Organellar Marker Levels Between Alzheimer's Disease and Frontotemporal Dementia.
    Krishna G; Santhoshkumar R; Sivakumar PT; Alladi S; Mahadevan A; Dahale AB; Arshad F; Subramanian S
    J Alzheimers Dis; 2023; 94(s1):S387-S397. PubMed ID: 36336935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
    Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
    J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.